Husband is on a clinical trial called B7-H3 antibody drug conjulate for stage 4 hormone resistant PCa with...
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Question asked:
Husband is on a clinical trial called B7-H3 antibody drug conjulate for stage 4 hormone resistant PCa with aggressive variant TP53 and PTEN also TMPRSS2-ERG
According to the NCCN Guidelines for Prostate Cancer (2023 version):
- TP53 and PTEN mutations are considered adverse prognostic factors in prostate cancer
- Genetic testing is recommended for all patients with metastatic prostate cancer to guide treatment decisions
- Clinical trials are considered appropriate options for patients with hormone-resistant (castration-resistant) prostate cancer
The American Society of Clinical Oncology (ASCO) guidelines note that:
- TMPRSS2-ERG fusion is one of the most common genetic alterations in prostate cancer
- B7-H3 (also known as CD276) is emerging as a promising therapeutic target in prostate cancer clinical trials
Regarding B7-H3 antibody-drug conjugates specifically, the National Cancer Institute (NCI) recognizes this as an active area of research for treating aggressive prostate cancers that have become resistant to standard hormonal therapies.
Important points to discuss with your husband's healthcare team:
- Regular monitoring of PSA levels and imaging
- Potential side effects specific to the clinical trial drug
- What other treatment options might be available if needed
Remember that clinical trials are carefully monitored, and your husband's treatment team will be closely tracking his response to therapy. Always report any new symptoms or concerns to the clinical trial team promptly.
Would you like more specific information about any of these aspects of his treatment?
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Prostate Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Prostate Cancer patients
Have your records handy? Upload them for a deeper, personalized analysis →